ArticleEuropean urology2021

Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial.

Brian I Rini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.